SLNO · Soleno Therapeutics Inc
$53.01
+0.00 (+0.00%)
At close · May 18
Market Cap
$2.76B
Shares
52.12M
Soleno Therapeutics Inc Earnings Call Transcripts
Every quarterly earnings call for Soleno Therapeutics Inc (SLNO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Conference
Investor event
2026-03-04
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-25
Soleno Therapeutics Inc Q4 FY2025 Earnings Call
Confident tone
VYKAT XR launch momentum and uptake
Geographic expansion into EU/UK
Safety, tolerability and discontinuation rate
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Soleno Therapeutics Inc Q3 FY2025 Earnings Call
Confident tone
VYKAT XR commercial launch
Discontinuations and adverse events
EU regulatory expansion (DCCR/MAA)
Revenue
$66.02M
Diluted EPS
$0.47
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-10
Soleno Therapeutics Inc Q2 FY2025 Earnings Call
Confident tone
Commercial launch of Vykat XR / DCCR
Patient uptake and prescriber adoption
Payer coverage and reimbursement
Revenue
$32.66M
Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Soleno Therapeutics Inc Q1 FY2025 Earnings Call
Confident tone
FDA approval and launch of VYKAT XR
Prader-Willi syndrome and hyperphagia unmet need
Competitive landscape
Diluted EPS
$-0.95
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-26
Soleno Therapeutics Inc Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–6 of 6 earnings calls